|
시장보고서
상품코드
1807461
세계의 효소 DNA 합성 시장 : 규모, 점유율 및 동향, 업계 분석(서비스별, 기술별, 용도별, 최종 용도별, 지역별), 예측(2025-2034년)Enzymatic DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Services (Oligonucleotide Synthesis and Gene Synthesis), By Technology, By Application, By End Use, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 효소 DNA 합성 시장 규모는 2034년까지 30억 6,336만 달러에 달할 전망입니다. 이 조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
효소 DNA 합성 기술은 기존의 화학 합성 방법과 관련된 효율, 오류율 및 환경 제한을 해결하면서 올리고뉴클레오티드를 보다 빠르고, 깨끗하고, 보다 정확하게 제조할 수 있기 때문에 생명공학, 제약 및 학술 연구 응용 분야에서 채용이 증가하고 있습니다.
정밀의료 및 합성 생물학 솔루션에 대한 수요 증가, 유전체학, 진단, 제약 연구에서 효소 합성의 응용 확대, 확장 가능하고 비용 효율적이며, 환경적으로 지속 가능한 DNA 제조 방법에 대한 요구 가속화로 시장이 크게 확대되고 있습니다. 효소 과정에서의 혁신 증가는 정부와 민간 조직의 지원 투자와 함께 이러한 기술의 채택을 더욱 촉진하고 있습니다.
효소 DNA 합성 시장 보고서 하이라이트
서비스별로는 올리고뉴클레오티드 합성 부문이 2024년 시장을 독점했습니다. 이는 고품질 합성 DNA를 필요로 하는 분자진단, PCR 분석, 차세대 시퀀싱, 표적 의약품 프로그램 등에서 널리 사용되기 때문입니다.
기술별로는 PCR 부문이 2024년에 가장 큰 점유율을 차지했습니다. 이는 연구 및 임상 진단에서의 확립된 역할 때문에 유전자 분석, 감염증 검출, 종양학 응용을 위한 고처리량 DNA 증폭을 가능하게 합니다.
용도별로는 유전자회로의 설계, 대사공학, 바이오의 재료, 연료, 첨단 치료제의 개발 등 합성 생물학이 널리 채용되고 있기 때문에 2024년에는 합성 생물학이 시장을 독점했습니다.
최종 용도별로는 효율적이고 정확하고 확장 가능한 DNA 합성 솔루션에 의존하는 유전자 기반 치료법, 정밀의료, 생물 제제 개발에 대한 관심 증가에 힘입어 바이오 의약품 기업 부문이 2024년 시장을 선도하고 있습니다.
북미는 2024년에 압도적인 점유율을 획득했는데, 이는 주요 생명공학 및 제약기업의 강한 존재감, 견고한 연구 인프라, 유전체학 및 생명과학 전반에 걸친 높은 R&D 투자에 기인합니다.
아시아태평양은 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예측됩니다. 이는 정부 자금 증가, 합성 생물학에 초점을 맞춘 국가적 이니셔티브, 중국, 인도, 싱가포르 등의 국가에서 확대되는 생명 과학 연구 거점이 뒷받침하고 있습니다.
세계 시장의 주요 기업은 Aldevron LLC(Danaher Corporation), Almac Group Limited, Ansa Biotechnologies, Inc., Biotium, Inc., Camena Bioscience Ltd., DNA Script SAS, Elegen Corporation, Evonetix Ltd., GenScript Biotech Corporation, Kern Systems, Inc., Merck KGaATouch Genetics Ltd., Twist Bioscience Corporation 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 효소 DNA 합성 시장 인사이트
- 시장 현황
- 효소 DNA 합성 시장 역학
- 성장 촉진요인과 기회
- 바이오 테크놀로지 분야의 확대가 첨단 DNA 합성 기술의 도입을 촉진
- 유전체 연구와 의약품 개발에서 연구 자금 증가
- 억제요인과 과제
- 높은 연구개발비와 한정된 상업규모의 생산능력
- 성장 촉진요인과 기회
- PESTLE 분석
- 효소 DNA 합성 시장 동향
- 밸류체인 분석
제5장 세계의 효소 DNA 합성 시장 : 서비스별
- 주요 분석 결과
- 소개
- 올리고뉴클레오티드 합성
- 유전자 합성
제6장 세계의 효소 DNA 합성 시장 : 기술별
- 주요 분석 결과
- 소개
- SOLA
- CRISPR
- PCR
제7장 세계의 효소 DNA 합성 시장 : 용도별
- 주요 분석 결과
- 소개
- 합성 생물학
- 유전자 공학
- 백신 개발
- 기타
제8장 세계의 효소 DNA 합성 시장 : 최종 용도별
- 주요 분석 결과
- 소개
- 바이오의약품기업
- 학술연구기관
- CRO(의약품 개발 업무 수탁 기관)
제9장 세계의 효소 DNA 합성 시장 : 지역별
- 주요 분석 결과
- 소개
- 효소 DNA 합성 시장의 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 서비스별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 서비스별(2020-2034년)
- 유럽 : 기술별（2020-2034년）
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 서비스별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 서비스별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 서비스별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제11장 기업 프로파일
- Aldevron LLC(Danaher Corporation)
- Almac Group Limited
- Ansa Biotechnologies, Inc.
- Biotium, Inc.
- Camena Bioscience Ltd.
- DNA Script SAS
- Elegen Corporation
- Evonetix Ltd.
- GenScript Biotech Corporationc
- Kern Systems, Inc.
- Merck KGaA
- Molecular Assemblies, Inc.
The enzymatic DNA synthesis market size is expected to reach USD 3,063.36 Million by 2034, according to a new study by Polaris Market Research. The report "Enzymatic DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Services (Oligonucleotide Synthesis and Gene Synthesis), By Technology, By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Enzymatic DNA synthesis technologies are increasingly adopted across biotechnology, pharmaceutical, and academic research applications, as it provide faster, cleaner, and more accurate production of oligonucleotides while addressing the efficiency, error rate, and environmental limitations associated with conventional chemical synthesis methods.
The market is expanding significantly due to the rising demand for precision medicine and synthetic biology solutions, the growing application of enzymatic synthesis in genomics, diagnostics, and pharmaceutical research, and the accelerating need for scalable, cost-effective, and environmentally sustainable DNA manufacturing methods. Rising innovations in enzymatic processes, coupled with supportive investments from governments and private organizations, are further enhancing the adoption of these technologies.
Enzymatic DNA Synthesis Market Report Highlights
Based on services, the oligonucleotide synthesis segment dominated the market in 2024, due to its extensive use in molecular diagnostics, PCR assays, next-generation sequencing, and targeted drug discovery programs that require high-quality synthetic DNA.
In terms of technology, PCR accounted for the largest share in 2024, owing to its established role in research and clinical diagnostics, enabling high-throughput DNA amplification for genetic analysis, infectious disease detection, and oncology applications.
In terms of application, synthetic biology is dominating the market in 2024, driven by its widespread adoption in designing genetic circuits, metabolic engineering, and developing bio-based materials, fuels, and advanced therapeutics.
Based on end use, the biopharmaceutical companies segment led the market in 2024, supported by the growing focus on developing gene-based therapies, precision medicine, and biologics that depend on efficient, accurate, and scalable DNA synthesis solutions.
North America captured a dominant share in 2024, attributed to the strong presence of leading biotechnology and pharmaceutical companies, robust research infrastructure, and high R&D investments across genomics and life sciences.
Asia Pacific is projected to record the fastest growth during the forecast period, fueled by rising government funding, national initiatives focused on synthetic biology, and expanding life sciences research hubs across countries such as China, India, and Singapore.
Key players in the global market include Aldevron LLC (Danaher Corporation), Almac Group Limited, Ansa Biotechnologies, Inc., Biotium, Inc., Camena Bioscience Ltd., DNA Script SAS, Elegen Corporation, Evonetix Ltd., GenScript Biotech Corporation, Kern Systems, Inc., Merck KGaA, Molecular Assemblies, Inc., Telesis Bio Inc., Touchlight Genetics Ltd., and Twist Bioscience Corporation.
Polaris Market Research has segmented the market report based on services, technology, application, end use, and region:
By Services Outlook (Revenue, USD Million, 2020-2034)
Oligonucleotide Synthesis
Gene Synthesis
By Technology Outlook (Revenue, USD Million, 2020-2034)
SOLA
CRISPR
PCR
By Application Outlook (Revenue, USD Million, 2020-2034)
Synthetic Biology
Genetic Engineering
Vaccine Development
Others
By End Use Outlook (Revenue, USD Million, 2020-2034)
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Enzymatic DNA Synthesis Market Insights
- 4.1. Enzymatic DNA Synthesis Market - Market Snapshot
- 4.2. Enzymatic DNA Synthesis Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Expanding Biotechnology Sector Driving Adoption of Advanced DNA Synthesis Technologies
- 4.2.1.2. Growing Research Funding in Genomic Research and Drug Development
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High R&D Costs and Limited Commercial-Scale Production Capabilities
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Enzymatic DNA Synthesis Market Trends
- 4.6. Value Chain Analysis
5. Global Enzymatic DNA Synthesis Market, by Services
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 5.3. Oligonucleotide Synthesis
- 5.3.1. Global Enzymatic DNA Synthesis Market, by Oligonucleotide Synthesis, by Region, 2020-2034 (USD Million)
- 5.4. Gene Synthesis
- 5.4.1. Global Enzymatic DNA Synthesis Market, by Gene Synthesis, by Region, 2020-2034 (USD Million)
6. Global Enzymatic DNA Synthesis Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 6.3. SOLA
- 6.3.1. Global Enzymatic DNA Synthesis Market, by SOLA, by Region, 2020-2034 (USD Million)
- 6.4. CRISPR
- 6.4.1. Global Enzymatic DNA Synthesis Market, by CRISPR, by Region, 2020-2034 (USD Million)
- 6.5. PCR
- 6.5.1. Global Enzymatic DNA Synthesis Market, by PCR, by Region, 2020-2034 (USD Million)
7. Global Enzymatic DNA Synthesis Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 7.3. Synthetic Biology
- 7.3.1. Global Enzymatic DNA Synthesis Market, by Synthetic Biology, by Region, 2020-2034 (USD Million)
- 7.4. Genetic Engineering
- 7.4.1. Global Enzymatic DNA Synthesis Market, by Genetic Engineering, by Region, 2020-2034 (USD Million)
- 7.5. Vaccine Development
- 7.5.1. Global Enzymatic DNA Synthesis Market, by Vaccine Development, by Region, 2020-2034 (USD Million)
- 7.6. Others
- 7.6.1. Global Enzymatic DNA Synthesis Market, by Others, by Region, 2020-2034 (USD Million)
8. Global Enzymatic DNA Synthesis Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 8.3. Biopharmaceutical Companies
- 8.3.1. Global Enzymatic DNA Synthesis Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Million)
- 8.4. Academic & Research Institutes
- 8.4.1. Global Enzymatic DNA Synthesis Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Million)
- 8.5. Contract Research Organizations
- 8.5.1. Global Enzymatic DNA Synthesis Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
9. Global Enzymatic DNA Synthesis Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Enzymatic DNA Synthesis Market Assessment, By Geography, 2020-2034 (USD Million)
- 9.3. Enzymatic DNA Synthesis Market - North America
- 9.3.1. North America: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.3.2. North America: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.3.3. North America: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.3.4. North America: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.3.5. Enzymatic DNA Synthesis Market - U.S.
- 9.3.5.1. U.S.: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.3.5.2. U.S.: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.3.5.3. U.S.: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.3.5.4. U.S.: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.3.6. Enzymatic DNA Synthesis Market - Canada
- 9.3.6.1. Canada: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.3.6.2. Canada: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.3.6.3. Canada: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.3.6.4. Canada: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4. Enzymatic DNA Synthesis Market - Europe
- 9.4.1. Europe: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.2. Europe: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.3. Europe: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.4. Europe: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.5. Enzymatic DNA Synthesis Market - UK
- 9.4.5.1. UK: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.5.2. UK: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.5.3. UK: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.5.4. UK: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.6. Enzymatic DNA Synthesis Market - France
- 9.4.6.1. France: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.6.2. France: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.6.3. France: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.6.4. France: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.7. Enzymatic DNA Synthesis Market - Germany
- 9.4.7.1. Germany: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.7.2. Germany: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.7.3. Germany: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.7.4. Germany: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.8. Enzymatic DNA Synthesis Market - Italy
- 9.4.8.1. Italy: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.8.2. Italy: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.8.3. Italy: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.8.4. Italy: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.9. Enzymatic DNA Synthesis Market - Spain
- 9.4.9.1. Spain: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.9.2. Spain: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.9.3. Spain: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.9.4. Spain: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.10. Enzymatic DNA Synthesis Market - Netherlands
- 9.4.10.1. Netherlands: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.10.2. Netherlands: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.10.3. Netherlands: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.10.4. Netherlands: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.11. Enzymatic DNA Synthesis Market - Russia
- 9.4.11.1. Russia: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.11.2. Russia: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.11.3. Russia: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.11.4. Russia: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.4.12. Enzymatic DNA Synthesis Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.4.12.2. Rest of Europe: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.4.12.3. Rest of Europe: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.4.12.4. Rest of Europe: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5. Enzymatic DNA Synthesis Market - Asia Pacific
- 9.5.1. Asia Pacific: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.5. Enzymatic DNA Synthesis Market - China
- 9.5.5.1. China: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.5.2. China: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.5.3. China: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.5.4. China: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.6. Enzymatic DNA Synthesis Market - India
- 9.5.6.1. India: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.6.2. India: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.6.3. India: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.6.4. India: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.7. Enzymatic DNA Synthesis Market - Malaysia
- 9.5.7.1. Malaysia: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.7.2. Malaysia: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.7.3. Malaysia: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.7.4. Malaysia: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.8. Enzymatic DNA Synthesis Market - Japan
- 9.5.8.1. Japan: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.8.2. Japan: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.8.3. Japan: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.8.4. Japan: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.9. Enzymatic DNA Synthesis Market - Indonesia
- 9.5.9.1. Indonesia: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.9.2. Indonesia: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.9.3. Indonesia: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.9.4. Indonesia: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.10. Enzymatic DNA Synthesis Market - South Korea
- 9.5.10.1. South Korea: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.10.2. South Korea: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.10.3. South Korea: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.10.4. South Korea: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.11. Enzymatic DNA Synthesis Market - Australia
- 9.5.11.1. Australia: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.11.2. Australia: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.11.3. Australia: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.11.4. Australia: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.5.12. Enzymatic DNA Synthesis Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6. Enzymatic DNA Synthesis Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6.5. Enzymatic DNA Synthesis Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.5.2. Saudi Arabia: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.5.3. Saudi Arabia: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.5.4. Saudi Arabia: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6.6. Enzymatic DNA Synthesis Market - UAE
- 9.6.6.1. UAE: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.6.2. UAE: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.6.3. UAE: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.6.4. UAE: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6.7. Enzymatic DNA Synthesis Market - Israel
- 9.6.7.1. Israel: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.7.2. Israel: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.7.3. Israel: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.7.4. Israel: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6.8. Enzymatic DNA Synthesis Market - South Africa
- 9.6.8.1. South Africa: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.8.2. South Africa: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.8.3. South Africa: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.8.4. South Africa: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.6.9. Enzymatic DNA Synthesis Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.7. Enzymatic DNA Synthesis Market - Latin America
- 9.7.1. Latin America: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.7.2. Latin America: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.7.3. Latin America: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.7.4. Latin America: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.7.5. Enzymatic DNA Synthesis Market - Mexico
- 9.7.5.1. Mexico: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.7.5.2. Mexico: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.7.5.3. Mexico: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.7.5.4. Mexico: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.7.6. Enzymatic DNA Synthesis Market - Brazil
- 9.7.6.1. Brazil: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.7.6.2. Brazil: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.7.6.3. Brazil: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.7.6.4. Brazil: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.7.7. Enzymatic DNA Synthesis Market - Argentina
- 9.7.7.1. Argentina: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.7.7.2. Argentina: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.7.7.3. Argentina: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.7.7.4. Argentina: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
- 9.7.8. Enzymatic DNA Synthesis Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Enzymatic DNA Synthesis Market, by Services, 2020-2034 (USD Million)
- 9.7.8.2. Rest of Latin America: Enzymatic DNA Synthesis Market, by Technology, 2020-2034 (USD Million)
- 9.7.8.3. Rest of Latin America: Enzymatic DNA Synthesis Market, by Application, 2020-2034 (USD Million)
- 9.7.8.4. Rest of Latin America: Enzymatic DNA Synthesis Market, by End Use, 2020-2034 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Aldevron LLC (Danaher Corporation)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Almac Group Limited
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Ansa Biotechnologies, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Biotium, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Camena Bioscience Ltd.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. DNA Script SAS
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Elegen Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Evonetix Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. GenScript Biotech Corporationc
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Kern Systems, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Merck KGaA
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Molecular Assemblies, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
